drugset / Trial / NCT04512898

Helicobacter Pylori Eradication and Irritable Bowel Syndrome: A Prospective Study

NCT04512898

Phase 4 Unknown 100 enrolled Assiut University
NaSingle-groupOpen-labelTreatment

Summary

H. Pylori is frequently observed in patients with irritable bowel syndrome(IBS). However, the effect of H. pylori eradication on IBS is not clear.

Timeline

Start
2020-08-10
Primary completion
2020-11-10
Completion
2020-11-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Clarithromycin Small molecule
Subject Metronidazole Small molecule